ALKBH5, a m6A demethylase, modulates target gene expression, generates an immunosuppressive tumor microenvironment and contributes to the efficacy of immunotherapy in melanoma, colorectal cancer and glioblastoma [42, 43]. Here, ALKBH5 is linked to neoplasm.